-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 7, 2022, the journal " Science Immunology " published online the collaborative research paper "A tumor-specific pro-IL-12 activates preexisting by Prof.
Interleukin 12 (IL-12) is a heterodimer composed of P35 and P40 subunits and is one of the main cytokines that induce cellular immunity
To extend the half-life of IL-12, the researchers first constructed a recombinant IL-12-Fc fusion protein
Further mechanism studies have found that pro-IL-12 can directly act on killer T cells (CTL) in tumors and promote their secretion of IFNγ to play an anti-tumor effect
Diyuan Xue, Ph.
Article link: https://
(Contributed by Peng Hua Research Group)